Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery

Stroke

Volumn 44, Issue 12, 2013, Pages 3407-3413

  Mathew, Joseph P ^a   White, William D ^a   Schinderle, David B ^a,b   Podgoreanu, Mihai V ^a   Berger, Miles ^a   Milano, Carmelo A ^a   Laskowitz, Daniel T ^a   Stafford Smith, Mark ^a   Blumenthal, James A ^a   Newman, Mark F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Sentara Cardiovascular Research Institute   (United States)

Author keywords

Blood platelets; Cardiopulmonary bypass; Cognition

Indexed keywords

CD11B ANTIGEN; MAGNESIUM; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; EDUCATION; FEMALE; FLUORESCENCE; HEART EJECTION FRACTION; HEART SURGERY; HEART VALVE SURGERY; HUMAN; INTRAOPERATIVE PERIOD; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; THROMBOCYTE ACTIVATION;

BLOOD PLATELETS; CARDIOPULMONARY BYPASS; COGNITION;

AGED; CARDIAC SURGICAL PROCEDURES; COGNITION; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOPERATIVE CARE; MAGNESIUM; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

EID: 84889246044     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002703     Document Type: Article

References (46)

1. Hogue CW Jr, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg. 2006;103:21-37.
2. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402.
3. Evered L, Scott DA, Silbert B, Maruff P. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic. Anesth Analg. 2011;112:1179-1185.
4. Selnes OA, Grega MA, Borowicz LM Jr, Royall RM, McKhann GM, Baumgartner WA. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003;75:1377-1884, discussion 1384.
5. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation. 2007;116:1888-1895.
6. Mathew JP, Mackensen GB, Phillips-Bute B, Grocott HP, Glower DD, Laskowitz DT, et al; Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke. 2009;40:880-887.
7. Mathew JP, Mackensen GB, Phillips-Bute B, Stafford-Smith M, Podgoreanu MV, Grocott HP, et al; Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology. 2007;107:577-584.
8. Mathew JP, Podgoreanu MV, Grocott HP, White WD, Morris RW, Stafford-Smith M, et al; PEGASUS Investigative Team. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J Am Coll Cardiol. 2007;49:1934-1942.
9. Mathew JP, Rinder HM, Smith BR, Newman MF, Rinder CS. Transcerebral platelet activation after aortic cross-clamp release is linked to neurocognitive decline. Ann Thorac Surg. 2006;81:1644-1649.
10. Puskas F, Grocott HP, White WD, Mathew JP, Newman MF, Bar-Yosef S. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg. 2007;84:1467-1473.
11. Grocott HP, Mackensen GB, Grigore AM, Mathew J, Reves JG, Phillips-Bute B, et al; Neurologic Outcome Research Group (NORG); Cardiothoracic Anesthesiology Research Endeavors (CARE) Investigators' of the Duke Heart Center. Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. Stroke. 2002;33:537-541.
12. Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, et al; Neurologic Outcome Research Group and the Cardiothoracic Anesthesia Research Endeavors (CARE) Investigators of the Duke Heart Center. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001;32:2874-2881.
13. Phillips-Bute B, Mathew JP, Blumenthal JA, Grocott HP, Laskowitz DT, Jones RH, et al. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med. 2006;68:369-375.
14. Lin JY, Chung SY, Lin MC, Cheng FC. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci. 2002;71:803-811.
15. Hoffman DJ, Marro PJ, McGowan JE, Mishra OP, Delivoria-Papadopoulos M. Protective effect of MgSO4 infusion on nmda receptor binding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res. 1994;644:144-149.
16. Billard JM. Ageing, hippocampal synaptic activity and magnesium. Magnes Res. 2006;19:199-215.
17. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr Treat Options Neurol. 2003;5:367-375.
18. Bartrup JT, Stone TW. Presynaptic actions of adenosine are magnesiumdependent. Neuropharmacology. 1988;27:761-763.
19. Strong JA, Scott SA. Divalent-selective voltage-independent calcium channels in Lymnaea neurons: permeation properties and inhibition by intracellular magnesium. J Neurosci. 1992;12:2993-3003.
20. Chi OZ, Pollak P, Weiss HR. Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther. 1990;304:196-205.
21. Sheu JR, Hsiao G, Shen MY, Fong TH, Chen YW, Lin CH, et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol. 2002;119:1033-1041.
22. Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke. 1998;29:2357-2362.
23. Murkin JM, Newman SP, Stump DA, Blumenthal JA. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995;59:1289-1295.
24. Randt C, Brown E. Administration Manual: Randt Memory Test. New York, NY: Life Sciences Associates; 1983.
25. Wechsler D. The Wechsler Adult Intelligence Scale-Revised (Manual). New York: Psychological Corporation; 1981.
26. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
27. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood. 1991;78:1730-1737.
28. Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol. 1999;6:342-348.
29. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 1991;78:1760-1769.
30. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201-1205.
31. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503-3521.
32. Xu X, Håkansson L. Degranulation of primary and secondary granules in adherent human neutrophils. Scand J Immunol. 2002;55:178-188.
33. Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 1995;96:1564-1572.
34. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res. 1998;11:43-56.
35. Afshari D, Moradian N, Rezaei M. Evaluation of the intravenous magnesium sulfate effect in clinical improvement of patients with acute ischemic stroke. Clin Neurol Neurosurg. 2013;115:400-404.
36. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, et al; MASH-2 Study Group. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 2012;380:44-49.
37. Muir KW, Lees KR, Ford I, Davis S; Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet. 2004;363:439-445.
38. Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol. 2007;6:29-38.
39. Mack WJ, Kellner CP, Sahlein DH, Ducruet AF, Kim GH, Mocco J, et al. Intraoperative magnesium infusion during carotid endarterectomy: a double-blind placebo-controlled trial. J Neurosurg. 2009;110:961-967.
40. Bhudia SK, Cosgrove DM, Naugle RI, Rajeswaran J, Lam BK, Walton E, et al. Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2006;131:853-861.
41. Brewer RP, Parra A, Borel CO, Hopkins MB, Reynolds JD. Intravenous magnesium sulfate does not increase ventricular CSF ionized magnesium concentration of patients with intracranial hypertension. Clin Neuropharmacol. 2001;24:341-345.
42. McKee JA, Brewer RP, Macy GE, Phillips-Bute B, Campbell KA, Borel CO, et al. Analysis of the brain bioavailability of peripherally administered magnesium sulfate: a study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med. 2005;33:661-666.
43. Merino JG, Latour LL, Tso A, Lee KY, Kang DW, Davis LA, et al. Bloodbrain barrier disruption after cardiac surgery. AJNR Am J Neuroradiol. 2013;34:518-523.
44. Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke. 1995;26:52-56.
45. Marquardt L, Ruf A, Mansmann U, Winter R, Schuler M, Buggle F, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33:2570-2574.
46. Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost. 1999;81:373-377.